Gene: TAF1D
Official Full Name: TATA-box binding protein associated factor, RNA polymerase I subunit Dprovided by HGNC
Gene Summary: TAF1D is a member of the SL1 complex, which includes TBP (MIM 600075) and TAF1A (MIM 604903), TAF1B (MIM 604904), and TAF1C (MIM 604905), and plays a role in RNA polymerase I transcription (Wang et al., 2004 [PubMed 15520167]; Gorski et al., 2007 [PubMed 17318177]).[supplied by OMIM, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13601 | TAF1D Knockout cell line (HeLa) | Human | TAF1D | 1:3~1:6 | Negative | Online Inquiry |
KO13602 | TAF1D Knockout cell line (HCT 116) | Human | TAF1D | 1:2~1:4 | Negative | Online Inquiry |
KO13603 | TAF1D Knockout cell line (HEK293) | Human | TAF1D | 1:3~1:6 | Negative | Online Inquiry |
TAF1D Gene Knockout Cell Lines are genetically engineered cellular models that specifically lack the TAF1D gene, which encodes a subunit of the transcription factor TFIID complex involved in RNA polymerase II-mediated transcription. These cell lines are invaluable tools for elucidating the role of TAF1D in gene regulation and its broader implications in cellular processes such as proliferation, differentiation, and response to stress.
The primary functionality of TAF1D Gene Knockout Cell Lines lies in their ability to facilitate the study of transcriptional regulation pathways by providing a controlled environment in which the absence of TAF1D can be investigated. Researchers can perform a variety of assays, including transcriptional reporter assays, cellular proliferation studies, and high-throughput screenings to discern the downstream effects of TAF1D absence. This model allows for in-depth analyses of gene expression profiles, post-transcriptional modifications, and protein interactions that are not possible in wild-type cells.
In terms of scientific importance, TAF1D knockout cell lines are pivotal for understanding diseases linked to transcriptional dysregulation, including cancer, neurodegenerative disorders, and autoimmune diseases. They provide a foundation for developing therapeutic interventions that target transcriptional machinery, which is often altered in various pathological states. Furthermore, these cell lines can be employed in drug discovery pipelines, enabling researchers to identify small molecules that can modulate transcriptional activity.
What sets TAF1D Gene Knockout Cell Lines apart from other genetic manipulation technologies is their specificity and reliability. Unlike transient transfection methods that can lead to variable expression levels and off-target effects, these knockout cell lines offer a stable and reproducible system for long-term studies. Researchers can be assured of the genomic integrity and functional relevance of these models for demanding applications.
For researchers and clinicians alike, the value of TAF1D Gene Knockout Cell Lines cannot be overstated. They empower scientists to dissect complex biological pathways with precision and contribute significantly to our understanding of fundamental cellular mechanisms. Our company specializes in developing high-quality genetically engineered models, ensuring that you have access to cutting-edge tools that propel your research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.